FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092960 [Registered on: 13/08/2025] Trial Registered Prospectively
Last Modified On: 23/07/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To study the oral effect of jyotishmati vati in patient of Artavkshaya 
Scientific Title of Study   A Randomized Open Labelled Controlled Clinical Trial To Assess An Effect Of Durva Swarasa Bhavit Jyotishmati Vati In Artavkshaya With Special Reference To Oligomenorrhea 
Trial Acronym  Nil  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shrikant Atmaram Dighe 
Designation  Ph. D Scholar 
Affiliation  R.A Podar Ayurved College  
Address  R.A Podar Ayurved College, Ground floor OPD number-8 Prasuti Tantra even Striroga department,Dr Annie Besant Road Worli Mumbai

Mumbai
MAHARASHTRA
400018
India 
Phone  9970664247  
Fax    
Email  digheshriikant@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bhagyashri Mahavir Khot 
Designation  Professar 
Affiliation  R.A Podar Ayurved College  
Address  R.A Podar Ayurved College, Dr Annie Besant Road Worli Mumbai

Mumbai
MAHARASHTRA
400018
India 
Phone  9850539489  
Fax    
Email  khotbhagyashri@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bhagyashri Mahavir Khot 
Designation  Professar 
Affiliation  R.A Podar Ayurved College  
Address  R.A Podar Ayurved College, Dr Annie Besant Road Worli Mumbai

Mumbai
MAHARASHTRA
400018
India 
Phone  9850539489  
Fax    
Email  khotbhagyashri@gmail.com  
 
Source of Monetary or Material Support  
R.A Podar Ayurved college and hospital ,Dr Annie Besant Road Worli Mumbai-400018 
 
Primary Sponsor  
Name  Dr Shrikant Atmaram Dighe 
Address  R.A Podar Ayurved College and hospital Dr Annie Besant Road Worli Mumbai-400018 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shrikant Atmaram Dighe  R.A Podar Ayurved college and hospital   R.A Podar Ayurved college and hospital ,Dr Annie Besant Road Worli Mumbai-400018
Mumbai
MAHARASHTRA 
9970664247

digheshriikant@gamil.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical committee RA Podar medical college Worli Mumbai   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N915||Oligomenorrhea, unspecified. Ayurveda Condition: ARTAVAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Jyotishmati vati, Reference: Bhaishajya Ratnavali , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Luke warm water), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Rajapravartini vati, Reference: Bhaishajya Ratnavali , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Luke warm water), Additional Information: -
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Selection irrespective of marital status, parity, socioeconomic status
Patients with sign and symptoms of Oligomenorrhea
Quantity of bleeding less than 80 mL
Hb should be greater than 8 gm%
BMI should be between 19 to 30 
 
ExclusionCriteria 
Details  Known patients of blood dyscrasias.
Known patients of major systemic diseases that are likely to influence menstrual rhythm. For e.g.; HTN, DM, TB, HIV, Thyroid, Nephrotic disorders.
Known patients of malignancy, cervical erosion, polyp, endometriosis, tubo- ovarian mass and PCOS/PCOD.
Known case of structural anomalies of genital organs.
Patients using IUCD’s.
Post Ligation Syndrome Patients
Patients who recently undergone Dilatation and Curettage Surgery.
Patients undergoing treatment for any other serious illness.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the efficacy of durva swaras bhavit jyotishmati vati in Artavkshaya with special reference to oligomenorrhea   3 months 
 
Secondary Outcome  
Outcome  TimePoints 
To study detail about Artavkshaya
To study properties of durva swaras bhavit jyotishmati vati 
3 months 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details
Modification(s)  
N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Study is randomised open labelled clinical trail to assess an effect of durva swaras bhavit jyotishmati vati in Artavkshaya with special reference to oligomenorrhea
Sample size is 90
There are two groups and each group has 45 samples
Group A is trial and group B is control group
Group A have durva swaras bhavit jyotishmati vati with Luke warm water 250mg BD for 90 days
Group B have Rajapravartini vati with Luke warm water 250mg BD for 90 days
Follow up on 30th day, 60th day, 90th day
Analysis of data and interpretation of result

 
Close